Internal Medicine 1417 - Internal Medicine Alert - Sep 15, 2010

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Author
Ralph R Hall, MD, FACP, FACSM
Professor of Medicine Emeritus
University of Missouri-Kansas City

Associate Editors
Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor
West Virginia University School of Medicine
Charleston, WV

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor, Assistant Director
Family Practice Residency
Program, University of Florida

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • One Screening Question to Help Identify Drug Use
  • Don't Get Too Tired — It's Bad for Your Heart
  • Are Carbohydrates Worse Than Saturated Fat? A New Paradigm
  • Olmesartan, Amlodipine, Hydrochlorothiazide Tablets (Tribenzorâ„¢)
  • Clinical Briefs
  • An Interpolated Tracing

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Amylin, Novo Nordisk, Shionogi Pharma, Takeda, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Novo Nordisk, and Teva. Associate editors Rahul Gupta, MD, MPH, FACP, Harold L. Karpman, MD, FACC, FACP, William T. Elliott, MD, FACP, James Chan, PharmD, PhD, author Ralph R Hall, MD, FACP, FACSM, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Louis Kuritzky, MD is a consultant for Abbott, AstraZeneca, Boehringer Ingelheim, Daiichi, Sankyo, Forest Pharmaceuticals, Lilly, Novo Nordisk, Takeda. Associate editor Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

Copyright 2010 AHC Media. All rights reserved.